Novartis aims to strengthen cell therapy capabilities with CellforCure acquisition
Novartis has announced plans to acquire CellforCure, a French contract development and manufacturing organisation (CDMO), from LFB for an undisclosed amount. The deal underscores the Swiss pharmaceutical giant’s ambition to solidify its leadership in the cell and gene therapy market. Strategic acquisition of a key player The acquisition includes CellforCure’s manufacturing facility in Les Ulis […]